nodes	percent_of_prediction	percent_of_DWPC	metapath
Temazepam—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0786	0.127	CbGbCtD
Temazepam—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0786	0.127	CbGbCtD
Temazepam—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.071	0.115	CbGbCtD
Temazepam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0653	0.105	CbGbCtD
Temazepam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0653	0.105	CbGbCtD
Temazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0501	0.0809	CbGbCtD
Temazepam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0495	0.0799	CbGbCtD
Temazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0339	0.0547	CbGbCtD
Temazepam—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.033	0.0533	CbGbCtD
Temazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0323	0.0522	CbGbCtD
Temazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0288	0.0465	CbGbCtD
Temazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0169	0.0273	CbGbCtD
Temazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.016	0.0258	CbGbCtD
Temazepam—Suicidal ideation—Roflumilast—chronic obstructive pulmonary disease	0.00632	0.026	CcSEcCtD
Temazepam—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.00603	0.0248	CcSEcCtD
Temazepam—Inappropriate antidiuretic hormone secretion—Aminophylline—chronic obstructive pulmonary disease	0.00508	0.0209	CcSEcCtD
Temazepam—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.00433	0.0178	CcSEcCtD
Temazepam—Sleep disturbance—Arformoterol—chronic obstructive pulmonary disease	0.00401	0.0165	CcSEcCtD
Temazepam—Sleep disturbance—Formoterol—chronic obstructive pulmonary disease	0.00401	0.0165	CcSEcCtD
Temazepam—Hostility—Montelukast—chronic obstructive pulmonary disease	0.00398	0.0164	CcSEcCtD
Temazepam—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.00392	0.0162	CcSEcCtD
Temazepam—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.00392	0.0162	CcSEcCtD
Temazepam—Coma—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.0111	CcSEcCtD
Temazepam—Aggression—Montelukast—chronic obstructive pulmonary disease	0.00251	0.0103	CcSEcCtD
Temazepam—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00247	0.0102	CcSEcCtD
Temazepam—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00995	CcSEcCtD
Temazepam—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.0024	0.00987	CcSEcCtD
Temazepam—Leukocytosis—Arformoterol—chronic obstructive pulmonary disease	0.00239	0.00985	CcSEcCtD
Temazepam—Leukocytosis—Formoterol—chronic obstructive pulmonary disease	0.00239	0.00985	CcSEcCtD
Temazepam—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00851	CcSEcCtD
Temazepam—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00851	CcSEcCtD
Temazepam—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00844	CcSEcCtD
Temazepam—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00205	0.00843	CcSEcCtD
Temazepam—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00803	CcSEcCtD
Temazepam—Tension—Roflumilast—chronic obstructive pulmonary disease	0.0019	0.00783	CcSEcCtD
Temazepam—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.00189	0.00777	CcSEcCtD
Temazepam—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.00189	0.00777	CcSEcCtD
Temazepam—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00188	0.00775	CcSEcCtD
Temazepam—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00187	0.00772	CcSEcCtD
Temazepam—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00186	0.00767	CcSEcCtD
Temazepam—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.00185	0.00761	CcSEcCtD
Temazepam—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00751	CcSEcCtD
Temazepam—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.00747	CcSEcCtD
Temazepam—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00179	0.00736	CcSEcCtD
Temazepam—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.00717	CcSEcCtD
Temazepam—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00705	CcSEcCtD
Temazepam—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00677	CcSEcCtD
Temazepam—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00628	CcSEcCtD
Temazepam—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00606	CcSEcCtD
Temazepam—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00597	CcSEcCtD
Temazepam—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00137	0.00566	CcSEcCtD
Temazepam—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.00561	CcSEcCtD
Temazepam—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00557	CcSEcCtD
Temazepam—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00555	CcSEcCtD
Temazepam—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00131	0.0054	CcSEcCtD
Temazepam—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.00536	CcSEcCtD
Temazepam—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00522	CcSEcCtD
Temazepam—Suicidal ideation—Prednisone—chronic obstructive pulmonary disease	0.00126	0.0052	CcSEcCtD
Temazepam—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00517	CcSEcCtD
Temazepam—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00507	CcSEcCtD
Temazepam—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00498	CcSEcCtD
Temazepam—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00495	CcSEcCtD
Temazepam—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00489	CcSEcCtD
Temazepam—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.00489	CcSEcCtD
Temazepam—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00485	CcSEcCtD
Temazepam—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.0048	CcSEcCtD
Temazepam—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00477	CcSEcCtD
Temazepam—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00473	CcSEcCtD
Temazepam—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.0047	CcSEcCtD
Temazepam—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.00467	CcSEcCtD
Temazepam—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00461	CcSEcCtD
Temazepam—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00453	CcSEcCtD
Temazepam—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00451	CcSEcCtD
Temazepam—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.0045	CcSEcCtD
Temazepam—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00448	CcSEcCtD
Temazepam—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00448	CcSEcCtD
Temazepam—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00445	CcSEcCtD
Temazepam—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00443	CcSEcCtD
Temazepam—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00441	CcSEcCtD
Temazepam—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00431	CcSEcCtD
Temazepam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.0043	CcSEcCtD
Temazepam—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00427	CcSEcCtD
Temazepam—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00424	CcSEcCtD
Temazepam—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00418	CcSEcCtD
Temazepam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00414	CcSEcCtD
Temazepam—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00414	CcSEcCtD
Temazepam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00099	0.00408	CcSEcCtD
Temazepam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000985	0.00406	CcSEcCtD
Temazepam—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.00403	CcSEcCtD
Temazepam—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00097	0.004	CcSEcCtD
Temazepam—Tension—Formoterol—chronic obstructive pulmonary disease	0.000965	0.00397	CcSEcCtD
Temazepam—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000965	0.00397	CcSEcCtD
Temazepam—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000955	0.00393	CcSEcCtD
Temazepam—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000955	0.00393	CcSEcCtD
Temazepam—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000951	0.00392	CcSEcCtD
Temazepam—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000951	0.00392	CcSEcCtD
Temazepam—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000945	0.00389	CcSEcCtD
Temazepam—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000945	0.00389	CcSEcCtD
Temazepam—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.000942	0.00388	CcSEcCtD
Temazepam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000939	0.00387	CcSEcCtD
Temazepam—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000933	0.00384	CcSEcCtD
Temazepam—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000926	0.00381	CcSEcCtD
Temazepam—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000921	0.00379	CcSEcCtD
Temazepam—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000921	0.00379	CcSEcCtD
Temazepam—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000916	0.00377	CcSEcCtD
Temazepam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000911	0.00375	CcSEcCtD
Temazepam—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000903	0.00372	CcSEcCtD
Temazepam—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000903	0.00372	CcSEcCtD
Temazepam—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000902	0.00371	CcSEcCtD
Temazepam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.00371	CcSEcCtD
Temazepam—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000898	0.0037	CcSEcCtD
Temazepam—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000892	0.00367	CcSEcCtD
Temazepam—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000885	0.00364	CcSEcCtD
Temazepam—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000884	0.00364	CcSEcCtD
Temazepam—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.00358	CcSEcCtD
Temazepam—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000869	0.00358	CcSEcCtD
Temazepam—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000869	0.00358	CcSEcCtD
Temazepam—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000853	0.00351	CcSEcCtD
Temazepam—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000851	0.0035	CcSEcCtD
Temazepam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00085	0.0035	CcSEcCtD
Temazepam—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000834	0.00344	CcSEcCtD
Temazepam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000834	0.00343	CcSEcCtD
Temazepam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000834	0.00343	CcSEcCtD
Temazepam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000834	0.00343	CcSEcCtD
Temazepam—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000832	0.00343	CcSEcCtD
Temazepam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00082	0.00338	CcSEcCtD
Temazepam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000819	0.00337	CcSEcCtD
Temazepam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000819	0.00337	CcSEcCtD
Temazepam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000817	0.00336	CcSEcCtD
Temazepam—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000816	0.00336	CcSEcCtD
Temazepam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00324	CcSEcCtD
Temazepam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000783	0.00322	CcSEcCtD
Temazepam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000783	0.00322	CcSEcCtD
Temazepam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000777	0.0032	CcSEcCtD
Temazepam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000773	0.00318	CcSEcCtD
Temazepam—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000769	0.00317	CcSEcCtD
Temazepam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00076	0.00313	CcSEcCtD
Temazepam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00075	0.00309	CcSEcCtD
Temazepam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00075	0.00309	CcSEcCtD
Temazepam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000746	0.00307	CcSEcCtD
Temazepam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00307	CcSEcCtD
Temazepam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000739	0.00304	CcSEcCtD
Temazepam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000732	0.00302	CcSEcCtD
Temazepam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000732	0.00302	CcSEcCtD
Temazepam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.00297	CcSEcCtD
Temazepam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000721	0.00297	CcSEcCtD
Temazepam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000715	0.00295	CcSEcCtD
Temazepam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.00295	CcSEcCtD
Temazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000713	0.00294	CcSEcCtD
Temazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000713	0.00294	CcSEcCtD
Temazepam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000708	0.00291	CcSEcCtD
Temazepam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000703	0.0029	CcSEcCtD
Temazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000699	0.00288	CcSEcCtD
Temazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000697	0.00287	CcSEcCtD
Temazepam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000692	0.00285	CcSEcCtD
Temazepam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000692	0.00285	CcSEcCtD
Temazepam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000686	0.00283	CcSEcCtD
Temazepam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000686	0.00283	CcSEcCtD
Temazepam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000684	0.00282	CcSEcCtD
Temazepam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000678	0.00279	CcSEcCtD
Temazepam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00278	CcSEcCtD
Temazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000674	0.00277	CcSEcCtD
Temazepam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00067	0.00276	CcSEcCtD
Temazepam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000661	0.00272	CcSEcCtD
Temazepam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000661	0.00272	CcSEcCtD
Temazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00066	0.00272	CcSEcCtD
Temazepam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000659	0.00271	CcSEcCtD
Temazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000657	0.00271	CcSEcCtD
Temazepam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000656	0.0027	CcSEcCtD
Temazepam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000653	0.00269	CcSEcCtD
Temazepam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000648	0.00267	CcSEcCtD
Temazepam—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000642	0.00265	CcSEcCtD
Temazepam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000632	0.0026	CcSEcCtD
Temazepam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000626	0.00258	CcSEcCtD
Temazepam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.00257	CcSEcCtD
Temazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000623	0.00256	CcSEcCtD
Temazepam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000613	0.00252	CcSEcCtD
Temazepam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000591	0.00243	CcSEcCtD
Temazepam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000591	0.00243	CcSEcCtD
Temazepam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00243	CcSEcCtD
Temazepam—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000589	0.00243	CcSEcCtD
Temazepam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000579	0.00238	CcSEcCtD
Temazepam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000576	0.00237	CcSEcCtD
Temazepam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000576	0.00237	CcSEcCtD
Temazepam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00234	CcSEcCtD
Temazepam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00234	CcSEcCtD
Temazepam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000564	0.00232	CcSEcCtD
Temazepam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.0023	CcSEcCtD
Temazepam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000556	0.00229	CcSEcCtD
Temazepam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000549	0.00226	CcSEcCtD
Temazepam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000549	0.00226	CcSEcCtD
Temazepam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.00224	CcSEcCtD
Temazepam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00221	CcSEcCtD
Temazepam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00221	CcSEcCtD
Temazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000531	0.00218	CcSEcCtD
Temazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000531	0.00218	CcSEcCtD
Temazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00052	0.00214	CcSEcCtD
Temazepam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00213	CcSEcCtD
Temazepam—Amoxapine—SLC6A4—chronic obstructive pulmonary disease	0.000514	0.112	CrCbGaD
Temazepam—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000511	0.00211	CcSEcCtD
Temazepam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00051	0.0021	CcSEcCtD
Temazepam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.0021	CcSEcCtD
Temazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000503	0.00207	CcSEcCtD
Temazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.00207	CcSEcCtD
Temazepam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.00207	CcSEcCtD
Temazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00206	CcSEcCtD
Temazepam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00206	CcSEcCtD
Temazepam—Depression—Prednisone—chronic obstructive pulmonary disease	0.000494	0.00203	CcSEcCtD
Temazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00203	CcSEcCtD
Temazepam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000488	0.106	CrCbGaD
Temazepam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00198	CcSEcCtD
Temazepam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000478	0.00197	CcSEcCtD
Temazepam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000477	0.00197	CcSEcCtD
Temazepam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00196	CcSEcCtD
Temazepam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00196	CcSEcCtD
Temazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00195	CcSEcCtD
Temazepam—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000468	0.00193	CcSEcCtD
Temazepam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00192	CcSEcCtD
Temazepam—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000461	0.0019	CcSEcCtD
Temazepam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00185	CcSEcCtD
Temazepam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000442	0.00182	CcSEcCtD
Temazepam—Ketazolam—ALB—chronic obstructive pulmonary disease	0.000435	0.0946	CrCbGaD
Temazepam—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00176	CcSEcCtD
Temazepam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000424	0.00175	CcSEcCtD
Temazepam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00042	0.00173	CcSEcCtD
Temazepam—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000402	0.0873	CrCbGaD
Temazepam—Amoxapine—HTR2A—chronic obstructive pulmonary disease	0.000395	0.0859	CrCbGaD
Temazepam—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000393	0.00162	CcSEcCtD
Temazepam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000365	0.0015	CcSEcCtD
Temazepam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.00147	CcSEcCtD
Temazepam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000356	0.00146	CcSEcCtD
Temazepam—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000354	0.0769	CrCbGaD
Temazepam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000348	0.00143	CcSEcCtD
Temazepam—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000347	0.00143	CcSEcCtD
Temazepam—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00034	0.0014	CcSEcCtD
Temazepam—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00138	CcSEcCtD
Temazepam—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.000329	0.0716	CrCbGaD
Temazepam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00135	CcSEcCtD
Temazepam—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000324	0.00244	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000324	0.00243	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000322	0.00242	CbGpPWpGaD
Temazepam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00132	CcSEcCtD
Temazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00032	0.0024	CbGpPWpGaD
Temazepam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000319	0.00239	CbGpPWpGaD
Temazepam—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000318	0.0692	CrCbGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000316	0.00238	CbGpPWpGaD
Temazepam—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000316	0.00237	CbGpPWpGaD
Temazepam—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000314	0.00236	CbGpPWpGaD
Temazepam—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000314	0.00236	CbGpPWpGaD
Temazepam—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000313	0.00235	CbGpPWpGaD
Temazepam—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000313	0.00235	CbGpPWpGaD
Temazepam—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000311	0.00234	CbGpPWpGaD
Temazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.0676	CrCbGaD
Temazepam—Shock—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00128	CcSEcCtD
Temazepam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00031	0.00233	CbGpPWpGaD
Temazepam—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000309	0.0671	CrCbGaD
Temazepam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00127	CcSEcCtD
Temazepam—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000307	0.0667	CrCbGaD
Temazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000305	0.0023	CbGpPWpGaD
Temazepam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00126	CcSEcCtD
Temazepam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000305	0.00229	CbGpPWpGaD
Temazepam—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000304	0.00228	CbGpPWpGaD
Temazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000304	0.00228	CbGpPWpGaD
Temazepam—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00124	CcSEcCtD
Temazepam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000299	0.00225	CbGpPWpGaD
Temazepam—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000299	0.00225	CbGpPWpGaD
Temazepam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000294	0.00221	CbGpPWpGaD
Temazepam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000292	0.0022	CbGpPWpGaD
Temazepam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000292	0.00219	CbGpPWpGaD
Temazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.00118	CcSEcCtD
Temazepam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000287	0.00216	CbGpPWpGaD
Temazepam—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000283	0.00213	CbGpPWpGaD
Temazepam—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00028	0.0021	CbGpPWpGaD
Temazepam—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.0021	CbGpPWpGaD
Temazepam—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000277	0.00208	CbGpPWpGaD
Temazepam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00208	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000276	0.00208	CbGpPWpGaD
Temazepam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00113	CcSEcCtD
Temazepam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000272	0.00112	CcSEcCtD
Temazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.00112	CcSEcCtD
Temazepam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000271	0.00203	CbGpPWpGaD
Temazepam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00111	CcSEcCtD
Temazepam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000268	0.00202	CbGpPWpGaD
Temazepam—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00201	CbGpPWpGaD
Temazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000267	0.00201	CbGpPWpGaD
Temazepam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00026	0.00107	CcSEcCtD
Temazepam—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000259	0.00195	CbGpPWpGaD
Temazepam—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000259	0.0563	CrCbGaD
Temazepam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00106	CcSEcCtD
Temazepam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000256	0.00192	CbGpPWpGaD
Temazepam—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00192	CbGpPWpGaD
Temazepam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000254	0.00191	CbGpPWpGaD
Temazepam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000251	0.00189	CbGpPWpGaD
Temazepam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000249	0.00187	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000247	0.00186	CbGpPWpGaD
Temazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.00184	CbGpPWpGaD
Temazepam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000244	0.00183	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000242	0.00182	CbGpPWpGaD
Temazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000242	0.00182	CbGpPWpGaD
Temazepam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00024	0.0018	CbGpPWpGaD
Temazepam—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000238	0.00179	CbGpPWpGaD
Temazepam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000238	0.00179	CbGpPWpGaD
Temazepam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000234	0.00176	CbGpPWpGaD
Temazepam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000958	CcSEcCtD
Temazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.00175	CbGpPWpGaD
Temazepam—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00172	CbGpPWpGaD
Temazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000229	0.00172	CbGpPWpGaD
Temazepam—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000228	0.00171	CbGpPWpGaD
Temazepam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000933	CcSEcCtD
Temazepam—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000225	0.00169	CbGpPWpGaD
Temazepam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00092	CcSEcCtD
Temazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00166	CbGpPWpGaD
Temazepam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.00165	CbGpPWpGaD
Temazepam—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00163	CbGpPWpGaD
Temazepam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00089	CcSEcCtD
Temazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00086	CcSEcCtD
Temazepam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000205	0.00154	CbGpPWpGaD
Temazepam—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000203	0.00153	CbGpPWpGaD
Temazepam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000827	CcSEcCtD
Temazepam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000815	CcSEcCtD
Temazepam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000197	0.00148	CbGpPWpGaD
Temazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000196	0.00147	CbGpPWpGaD
Temazepam—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.00146	CbGpPWpGaD
Temazepam—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00142	CbGpPWpGaD
Temazepam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000772	CcSEcCtD
Temazepam—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00139	CbGpPWpGaD
Temazepam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00018	0.00135	CbGpPWpGaD
Temazepam—Diazepam—ALB—chronic obstructive pulmonary disease	0.00018	0.039	CrCbGaD
Temazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00134	CbGpPWpGaD
Temazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.00132	CbGpPWpGaD
Temazepam—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.0013	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000168	0.00126	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000166	0.00124	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000164	0.00123	CbGpPWpGaD
Temazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.0012	CbGpPWpGaD
Temazepam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.0012	CbGpPWpGaD
Temazepam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00119	CbGpPWpGaD
Temazepam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000149	0.00112	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000148	0.00112	CbGpPWpGaD
Temazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00109	CbGpPWpGaD
Temazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.00108	CbGpPWpGaD
Temazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00107	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00014	0.00105	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000139	0.00104	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00103	CbGpPWpGaD
Temazepam—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00102	CbGpPWpGaD
Temazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.000981	CbGpPWpGaD
Temazepam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.000975	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000125	0.000941	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000124	0.00093	CbGpPWpGaD
Temazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.000885	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.000876	CbGpPWpGaD
Temazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000115	0.000864	CbGpPWpGaD
Temazepam—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.000864	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000115	0.000863	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000114	0.000858	CbGpPWpGaD
Temazepam—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000113	0.000851	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000113	0.000848	CbGpPWpGaD
Temazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00011	0.000825	CbGpPWpGaD
Temazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00011	0.000825	CbGpPWpGaD
Temazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.000793	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000106	0.000793	CbGpPWpGaD
Temazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.000783	CbGpPWpGaD
Temazepam—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000104	0.000782	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.000782	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.000771	CbGpPWpGaD
Temazepam—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.000752	CbGpPWpGaD
Temazepam—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.87e-05	0.000741	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.86e-05	0.000741	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.72e-05	0.000731	CbGpPWpGaD
Temazepam—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.59e-05	0.00072	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.49e-05	0.000713	CbGpPWpGaD
Temazepam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.36e-05	0.000703	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.17e-05	0.000689	CbGpPWpGaD
Temazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.04e-05	0.000679	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.93e-05	0.000671	CbGpPWpGaD
Temazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.9e-05	0.000669	CbGpPWpGaD
Temazepam—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.81e-05	0.000662	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.8e-05	0.000661	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.8e-05	0.000661	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.68e-05	0.000652	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.56e-05	0.000643	CbGpPWpGaD
Temazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.56e-05	0.000643	CbGpPWpGaD
Temazepam—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.47e-05	0.000636	CbGpPWpGaD
Temazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.42e-05	0.000633	CbGpPWpGaD
Temazepam—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.35e-05	0.000628	CbGpPWpGaD
Temazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.32e-05	0.000625	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	8.05e-05	0.000605	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.02e-05	0.000603	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.97e-05	0.000599	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.91e-05	0.000595	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.86e-05	0.000591	CbGpPWpGaD
Temazepam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.8e-05	0.000586	CbGpPWpGaD
Temazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.61e-05	0.000572	CbGpPWpGaD
Temazepam—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.56e-05	0.000568	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.53e-05	0.000566	CbGpPWpGaD
Temazepam—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.46e-05	0.00056	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.45e-05	0.00056	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.44e-05	0.000559	CbGpPWpGaD
Temazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.39e-05	0.000555	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.27e-05	0.000546	CbGpPWpGaD
Temazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.26e-05	0.000545	CbGpPWpGaD
Temazepam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.17e-05	0.000539	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.13e-05	0.000536	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.08e-05	0.000532	CbGpPWpGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.96e-05	0.000523	CbGpPWpGaD
Temazepam—GABRR1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.91e-05	0.000519	CbGpPWpGaD
Temazepam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.89e-05	0.000518	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.81e-05	0.000512	CbGpPWpGaD
Temazepam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.8e-05	0.000511	CbGpPWpGaD
Temazepam—GABRR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.59e-05	0.000495	CbGpPWpGaD
Temazepam—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.59e-05	0.000495	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.39e-05	0.00048	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.26e-05	0.00047	CbGpPWpGaD
Temazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.17e-05	0.000464	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.08e-05	0.000457	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.08e-05	0.000457	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.55e-05	0.000417	CbGpPWpGaD
Temazepam—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.43e-05	0.000408	CbGpPWpGaD
Temazepam—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.34e-05	0.000402	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.33e-05	0.000401	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.22e-05	0.000392	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	5.19e-05	0.00039	CbGpPWpGaD
Temazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.15e-05	0.000387	CbGpPWpGaD
Temazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.15e-05	0.000387	CbGpPWpGaD
Temazepam—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.06e-05	0.00038	CbGpPWpGaD
Temazepam—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.99e-05	0.000375	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.86e-05	0.000365	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.82e-05	0.000362	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.8e-05	0.00036	CbGpPWpGaD
Temazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.73e-05	0.000355	CbGpPWpGaD
Temazepam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.57e-05	0.000343	CbGpPWpGaD
Temazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.55e-05	0.000342	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.51e-05	0.000339	CbGpPWpGaD
Temazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.000337	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.48e-05	0.000336	CbGpPWpGaD
Temazepam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.44e-05	0.000333	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.39e-05	0.00033	CbGpPWpGaD
Temazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.36e-05	0.000327	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.34e-05	0.000326	CbGpPWpGaD
Temazepam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.28e-05	0.000322	CbGpPWpGaD
Temazepam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.25e-05	0.00032	CbGpPWpGaD
Temazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.18e-05	0.000314	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.08e-05	0.000307	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.03e-05	0.000303	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4e-05	0.0003	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.95e-05	0.000297	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.92e-05	0.000294	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.67e-05	0.000276	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.66e-05	0.000275	CbGpPWpGaD
Temazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.65e-05	0.000274	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.64e-05	0.000274	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.64e-05	0.000274	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.57e-05	0.000269	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.32e-05	0.00025	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.25e-05	0.000244	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.9e-05	0.000218	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.83e-05	0.000213	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.8e-05	0.00021	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.000199	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.56e-05	0.000192	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.42e-05	0.000182	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.4e-05	0.00018	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.37e-05	0.000178	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.36e-05	0.000177	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.35e-05	0.000177	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.21e-05	0.000166	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.19e-05	0.000165	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.16e-05	0.000163	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.14e-05	0.000161	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.12e-05	0.000159	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.99e-05	0.00015	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.97e-05	0.000148	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.96e-05	0.000148	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.95e-05	0.000147	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.94e-05	0.000146	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.93e-05	0.000145	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.93e-05	0.000145	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.8e-05	0.000136	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000135	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.000134	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.76e-05	0.000132	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-05	0.000129	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.66e-05	0.000125	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.64e-05	0.000123	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.62e-05	0.000122	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.53e-05	0.000115	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.000112	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.00011	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.000109	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.000102	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.35e-05	0.000102	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.33e-05	0.0001	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	9.71e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.29e-05	9.67e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	9.56e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.24e-05	9.34e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	8.86e-05	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	8.74e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	8.73e-05	CbGpPWpGaD
Temazepam—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	8.36e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	8.04e-05	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.85e-06	7.4e-05	CbGpPWpGaD
Temazepam—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.42e-06	7.08e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.92e-06	6.71e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.8e-06	6.61e-05	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	8.79e-06	6.6e-05	CbGpPWpGaD
Temazepam—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	8.41e-06	6.32e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.2e-06	6.16e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.01e-06	6.02e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.77e-06	5.84e-05	CbGpPWpGaD
Temazepam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.66e-06	5.76e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.28e-06	3.97e-05	CbGpPWpGaD
Temazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.05e-06	3.8e-05	CbGpPWpGaD
